National Cancer Institute; Notice of Meeting, 83101 [2020-28100]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 245 / Monday, December 21, 2020 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institute of Dental and
Craniofacial Research, National Institutes of
Health, 6701 Democracy Boulevard, Suite
670, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Yun Mei, MD, Scientific
Review Officer, Scientific Review Branch,
National Institute of Dental and Craniofacial,
Research National Institutes of Health, 6701
Democracy Boulevard, Suite 670, Bethesda,
MD 20892, (301) 827–4639, yun.mei@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: December 15, 2020.
Patricia B. Hansberger,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
BILLING CODE 4140–01–P
[FR Doc. 2020–28100 Filed 12–18–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Institutional
Network Applications for Promoting Kidney,
Urologic, and Hematologic Research Training
(U2C–TL1).
Date: March 9–10, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Video
Meeting).
Contact Person: Jason D. Hoffert, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK National Institutes of Health,
Room 7343, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 496–9010,
hoffertj@niddk.nih.gov.
Jkt 253001
[FR Doc. 2020–28003 Filed 12–18–20; 8:45 am]
Dated: December 15, 2020.
Patricia B. Hansberger,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
National Cancer Institute; Notice of
Meeting
BILLING CODE 4140–01–P
22:33 Dec 18, 2020
Dated: December 15, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
National Institutes of Health
[FR Doc. 2020–28097 Filed 12–18–20; 8:45 am]
VerDate Sep<11>2014
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
83101
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the President’s Cancer Panel.
The meeting will be held as a virtual
meeting and open to the public.
Individuals who plan to view the virtual
meeting and need special assistance or
other reasonable accommodations to
view the meeting should notify the
Contact Person listed below in advance
of the meeting. The meeting can be
accessed by clicking on the following
link: https://nci.rev.vbrick.com/#/
webcasts/presidentscancerpanel.
Name of Committee: President’s Cancer
Panel.
Date: February 11, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: Improving Resilience and Equity
in Cancer Screening: Innovation to Increase
Screening.
Place: National Institutes of Health 31
Center Drive, Building 31, Room 11A48,
Rockville, MD 20850 (Virtual Meeting)
Access to Meeting: https://
nci.rev.vbrick.com/#/webcasts/
presidentscancerpanel.
Contact Person: Maureen R. Johnson,
Ph.D., Executive Secretary, President’s
Cancer Panel, Special Assistant to the
Director, National Cancer Institute, NIH, 31
Center Drive, Room 11A48 MSC 2590,
Bethesda, MD 20892, 240–781–3327,
johnsonr@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/pcp/index.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
National Institute on Alcohol Abuse
and Alcoholism; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council on Alcohol Abuse and
Alcoholism.
The meeting will be held as a virtual
meeting and is open to the public as
indicated below. Individuals who plan
to view the virtual meeting and need
special assistance or other reasonable
accommodations to view the meeting,
should notify the Contact Person listed
below in advance of the meeting. The
open session will be videocast and can
be accessed from the NIH Videocasting
and Podcasting website (https://
videocast.nih.gov/).
A portion of the meeting will be
closed to the public in accordance with
the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The intramural programs
and projects as well as the grant
applications and/or contract proposals
and the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with intramural
programs and projects as well as the
grant applications and/or contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Alcohol Abuse and Alcoholism.
Date: February 4, 2021.
Closed: 11:00 a.m. to 11:30 a.m.
Agenda: Presentation of the AABSC
Report.
Closed: 11:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Open: 12:30 p.m. to 5:00 p.m.
Agenda: Presentations and other business
of the Council.
E:\FR\FM\21DEN1.SGM
21DEN1
]]>Agencies
[Federal Register Volume 85, Number 245 (Monday, December 21, 2020)]
[Notices]
[Page 83101]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-28100]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the President's Cancer
Panel.
The meeting will be held as a virtual meeting and open to the
public. Individuals who plan to view the virtual meeting and need
special assistance or other reasonable accommodations to view the
meeting should notify the Contact Person listed below in advance of the
meeting. The meeting can be accessed by clicking on the following link:
https://nci.rev.vbrick.com/#/webcasts/presidentscancerpanel.
Name of Committee: President's Cancer Panel.
Date: February 11, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: Improving Resilience and Equity in Cancer Screening:
Innovation to Increase Screening.
Place: National Institutes of Health 31 Center Drive, Building
31, Room 11A48, Rockville, MD 20850 (Virtual Meeting) Access to
Meeting: https://nci.rev.vbrick.com/#/webcasts/presidentscancerpanel.
Contact Person: Maureen R. Johnson, Ph.D., Executive Secretary,
President's Cancer Panel, Special Assistant to the Director,
National Cancer Institute, NIH, 31 Center Drive, Room 11A48 MSC
2590, Bethesda, MD 20892, 240-781-3327, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/pcp/index.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: December 15, 2020.
Patricia B. Hansberger,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2020-28100 Filed 12-18-20; 8:45 am]
BILLING CODE 4140-01-P
